Interestingly, our evaluation revealed that the Ki67 of the primary tumor cells was higher than that of the metastatic tumors, suggesting a decreased proliferative capacity of the tumor cells after metastasis, which may be related to the patient’s treatment (Table 2). The gene discussed is MKI67; the disease is metastatic neoplasm.